Clinical Trial Update: ACZ885 for the Treatment of Abdominal Aortic Aneurysm [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ACZ885 in abdominal aortic aneurysm has terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• ACZ885 (canakinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Abdominal Aortic Aneurysm (AAA) | Phase 2 | Status: TERMINATED | Results posted: 2016-11-21